|- candidate number||4338|
|- NTR Number||NTR1524|
|- ISRCTN||ISRCTN wordt niet meer aangevraagd|
|- Date ISRCTN created|
|- date ISRCTN requested|
|- Date Registered NTR||5-nov-2008|
|- Secondary IDs||08/218 MEC AMC|
|- Public Title||Decision aid Evaluation by a Clinical trial in Abdominal aortic aneurysms: Improving Decision making.|
|- Scientific Title||A randomised trial on communicating evidence with a decision aid in abdominal aortic aneurysm surgery: improving informed decision making in patients and surgeons.|
|- hypothesis||Providing AAA patients with a decision aid concerning watchful waiting or elective surgery will decrease their decisional conflict, increase their knowledge on treatment options, increase satisfaction and increase quality of life.|
|- Healt Condition(s) or Problem(s) studied||Abdominal Aortic Aneurysm, Medical decision making|
|- Inclusion criteria||1. Patients newly diagnosed with an AAA based on ultrasonography (and CT-scanning in the case of an aneurysm of 5.5 cm and more). |
2. Age >18 years.
3. Compos mentis.
|- Exclusion criteria||1. Life expectancy of <1 year.|
2. Insufficient knowledge of the Dutch language.
|- mec approval received||yes|
|- multicenter trial||yes|
|- control||Not applicable|
|- Type||2 or more arms, randomized|
|- planned startdate ||3-nov-2008|
|- planned closingdate||1-feb-2011|
|- Target number of participants||170|
|- Interventions||A decision aid concerning the choice between watchful waiting and elective surgery of an AAA.|
(The decision aid consists of information on AAA, medical evidence on benefits and risks of both treatment options, and it elicits patients' preferences)
|- Primary outcome||- Decisional Conflict|
|- Secondary outcome||- Knowledge|
- Quality of Life
|- Timepoints||T0: inclusion and randomisation of the patient, first set of questionnaires|
T1: patients in the intervention group study the decision aid
T2: second set of questionnaires after the treatment choice is made
T3: third set of questionnaires 3 months after T2
T4: fourth set of questionnaires 6 months after T3
|- Trial web site||N/A|
|- status||stopped: trial finished|
|- CONTACT FOR PUBLIC QUERIES||Dr. A. Goossens|
|- CONTACT for SCIENTIFIC QUERIES||Dr. A. Goossens|
|- Sponsor/Initiator ||Academic Medical Center (AMC), Department of Surgery, Academic Medical Center (AMC), Department of Quality Assurance & Process Innovation , Academic Medical Center (AMC), Department of Medical Psychology|
(Source(s) of Monetary or Material Support)
|Academic Medical Center (AMC)|
|- Brief summary||Background of the study:|
Prevalence of the Abdominal Aortic Aneurysm (AAA) is 6% among the elderly male population. AAA is an asymptomatic disease, but implies a risk of rupture of the aneurysm. Whenever this occurs, the majority of patients will die due to severe internal bleeding within 24 hours. An elective operation can prevent rupture of the aneurysm, but may also induce mortality or severe morbidity due to the very procedure.
For surgeons, the choice between the risk of rupture during watchful waiting, or the risk of complications due to surgery is usually not clear-cut, mostly due to comorbid conditions with the patient. Therefore, patient preferences are of paramount importance.
A decision aid regarding treatment options for AAA could help patients and surgeons to make an informed choice. Decision aids translate scientific evidence regarding (the pro's and con's of) the treatment options into comprehensible patient information.
Moreover, patient preferences are elicited in the decision aid. Previous research has shown that patients' decisional conflict decreases, comprehension of treatment options increases, patients have more realistic expectations and they are more actively participating in decision making.
Objective of the study:
In this study, the effect of a decision aid regarding the choice between watchful waiting or surgical treatment of AAA is explored, regarding decisional conflict, knowledge, satisfaction, quality of life, anxiety and clinical endpoints.
Randomised clinical trial, in which 170 subjects are randomised between (1) standard care and (2) standard care + decision aid
Eligible trial participants are patients newly diagnosed with an infrarenal AAA presenting for the first time at one the outpatient clinics of the participating hospitals to discuss their treatment options. Inclusion criteria are: patients diagnosed with an AAA based on ultrasonography (and CT-scanning in the case of an aneurysm of 5.5 cm and more), age >18 years and compos mentis. Exclusion criteria are: life expectancy of <6 months, insufficient knowledge of the Dutch language.
Intervention (if applicable):
Decision aid, comprising an interactive computer programme.
Primary study parameters/outcome of the study:
Secundary study parameters/outcome of the study (if applicable):
- Quality of life
Clinical enpoints (mortality, severe 30-day morbidity due to operation, rupture during watchful waiting)
Nature and extent of the burden and risks associated with participation, benefit and group relatedness (if applicable):
Because trial participation does not influence medical treatment, subjects will suffer no (physical) risks. Subjects are requested to spend time to complete 5 questionnaires (with in total 70 items) at 4 points in time, from the first visit to the outpatient clinic to 9 months after their treatment decision. Subjects in the intervention arm might be frightened by the additional information provided to them in the decision aid.
|- Main changes (audit trail)|
|- RECORD||5-nov-2008 - 28-aug-2012|